Patent · US Active

Derivation of embryonic stem cells and embryo-derived cells

US7893315B2 · kind B2 · utility

28Cited by
0References
26Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 3, 2007
Grant dateFeb 22, 2011
Priority date
Expiry dateMay 3, 2027

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2506/02
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

This present invention provides novel methods for deriving embryonic stem cells and embryo-derived cells from an embryo without requiring destruction of the embryo. The invention further provides cells and cell lines derived without embryo destruction, and the use of the cells for therapeutic and research purposes. It also relates to novel methods of establishing and storing an autologous stem cell line prior to implantation of an embryo, e.g., in conjunction with reproductive therapies such as IVF.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.